PANCREAZE DR 21,000 UNIT CAP
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE$5.7732per EA
Strength
83900; 21000; 54700 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Vivus LLCNDC
62541040510
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
1/19/2022
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022523On Market Since
4/12/2010
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.